Discontinuous Echocardiographic Subcostal Cardiac Output Measurement

Condition(s) studied

Investigational drug(s) / intervention(s)

Discontinuous subcostal echocardiographic cardiac output assessment: Right Ventricular Outflow Chamber Diameter (RVOD) and Left Ventricular Outflow Chamber Diameter (LVOD) assessments via subcostal approach

Study summary

Cardiac output (CO) monitoring is recommended for the most serious and multiple-failure patients in critical care and allows the diagnosis of acute circulatory failure as well as its etiology and also allows the monitoring of treatments. However, although allowing an adaptation of hemodynamic treatments and being integrated into a therapeutic personalization approach in situations of acute circulatory failure, the measurement of CO is conditioned by the availability of devices, by their sometimes problematic invasiveness, as well as their cost. In addition, the discontinuous measurement of CO by echocardiography is made difficult in the context of resuscitation with patients who are less mobilizable and less echogenic.

Eligibility

Primary outcome measure(s)

• Measurement of Cardiac Output (CO) via the subcostal route — At Enrollment visit and DAY 28
  To assess the concordance of the measurement of cardiac output in the ejection chamber of the right ventricle (DC-CEVD, innovative method) with that of cardiac output in the ejection chamber of the left ventricle (DC-CEVG, reference method) on subcostal transthoracic ultrasound (TTE).

Trial sites (1)

More University Hospital, Rouen trials in France